Annual Shareholders Equity
$871.96 M
-$178.21 M-16.97%
December 31, 2024
Summary
- As of March 6, 2025, NTLA annual stockholders equity is $871.96 million, with the most recent change of -$178.21 million (-16.97%) on December 31, 2024.
- During the last 3 years, NTLA annual shareholders equity has fallen by -$168.29 million (-16.18%).
- NTLA annual shareholders equity is now -29.43% below its all-time high of $1.24 billion, reached on December 31, 2022.
Performance
NTLA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$871.96 M
-$90.66 M-9.42%
December 31, 2024
Summary
- As of March 6, 2025, NTLA quarterly stockholders equity is $871.96 million, with the most recent change of -$90.66 million (-9.42%) on December 31, 2024.
- Over the past year, NTLA quarterly shareholders equity has dropped by -$164.18 million (-15.85%).
- NTLA quarterly shareholders equity is now -29.43% below its all-time high of $1.24 billion, reached on December 31, 2022.
Performance
NTLA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NTLA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -15.8% |
| 3 y3 years | -16.2% | -16.2% |
| 5 y5 years | +223.1% | +223.1% |
NTLA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | -29.4% | +5.7% |
| 5 y | 5-year | -29.4% | +223.1% | -29.4% | +251.9% |
| alltime | all time | -29.4% | +4212.8% | -29.4% | +3312.6% |
Intellia Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $871.96 M(-17.0%) | $871.96 M(-9.4%) |
| Sep 2024 | - | $962.62 M(-0.9%) |
| Jun 2024 | - | $971.06 M(-6.3%) |
| Mar 2024 | - | $1.04 B(-1.3%) |
| Dec 2023 | $1.05 B(-15.0%) | $1.05 B(+1.2%) |
| Sep 2023 | - | $1.04 B(-6.1%) |
| Jun 2023 | - | $1.10 B(-7.2%) |
| Mar 2023 | - | $1.19 B(-3.6%) |
| Dec 2022 | $1.24 B(+18.8%) | $1.24 B(+49.8%) |
| Sep 2022 | - | $824.95 M(-6.3%) |
| Jun 2022 | - | $880.55 M(-7.7%) |
| Mar 2022 | - | $953.75 M(-8.3%) |
| Dec 2021 | $1.04 B(+97.4%) | $1.04 B(-6.0%) |
| Sep 2021 | - | $1.11 B(+123.7%) |
| Jun 2021 | - | $494.81 M(-9.4%) |
| Mar 2021 | - | $545.87 M(+3.6%) |
| Dec 2020 | $527.07 M | $527.07 M(+59.9%) |
| Sep 2020 | - | $329.62 M(-6.2%) |
| Jun 2020 | - | $351.59 M(+41.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $247.76 M(-8.2%) |
| Dec 2019 | $269.88 M(-2.9%) | $269.88 M(-2.1%) |
| Sep 2019 | - | $275.65 M(-0.4%) |
| Jun 2019 | - | $276.87 M(+4.7%) |
| Mar 2019 | - | $264.34 M(-4.9%) |
| Dec 2018 | $277.92 M(-7.5%) | $277.92 M(+5.6%) |
| Sep 2018 | - | $263.27 M(-5.8%) |
| Jun 2018 | - | $279.34 M(-5.5%) |
| Mar 2018 | - | $295.50 M(-1.7%) |
| Dec 2017 | $300.60 M(+43.3%) | $300.60 M(+70.9%) |
| Sep 2017 | - | $175.85 M(-6.3%) |
| Jun 2017 | - | $187.59 M(-6.2%) |
| Mar 2017 | - | $199.88 M(-4.7%) |
| Dec 2016 | $209.84 M(-1089.8%) | $209.84 M(-3.8%) |
| Sep 2016 | - | $218.12 M(-2.4%) |
| Jun 2016 | - | $223.60 M(-923.8%) |
| Mar 2016 | - | -$27.14 M(+28.0%) |
| Dec 2015 | -$21.20 M(-380.2%) | -$21.20 M |
| Dec 2014 | $7.57 M | - |
FAQ
- What is Intellia Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Intellia Therapeutics?
- What is Intellia Therapeutics annual shareholders equity year-on-year change?
- What is Intellia Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly shareholders equity year-on-year change?
What is Intellia Therapeutics annual stockholders equity?
The current annual shareholders equity of NTLA is $871.96 M
What is the all time high annual shareholders equity for Intellia Therapeutics?
Intellia Therapeutics all-time high annual stockholders equity is $1.24 B
What is Intellia Therapeutics annual shareholders equity year-on-year change?
Over the past year, NTLA annual stockholders equity has changed by -$178.21 M (-16.97%)
What is Intellia Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of NTLA is $871.96 M
What is the all time high quarterly shareholders equity for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly stockholders equity is $1.24 B
What is Intellia Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, NTLA quarterly stockholders equity has changed by -$164.18 M (-15.85%)